Related references
Note: Only part of the references are listed.Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial
Michelle Rosenzwajg et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Promotion of Calcium/Calmodulin-Dependent Protein Kinase 4 by GLUT1-Dependent Glycolysis in Systemic Lupus Erythematosus
Tomohiro Koga et al.
ARTHRITIS & RHEUMATOLOGY (2019)
The role of CaMK4 in immune responses
Tomohiro Koga et al.
MODERN RHEUMATOLOGY (2018)
CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease
Kayaho Maeda et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial
Zhi-Wei Lai et al.
LANCET (2018)
A case of refractory lupus nephritis complicated by psoriasis vulgaris that was controlled with secukinumab
Y. Satoh et al.
LUPUS (2018)
Metabolism as a Target for Modulation in Autoimmune Diseases
Nick Huang et al.
TRENDS IN IMMUNOLOGY (2018)
Blockade of Treg Cell Differentiation and Function by the Interleukin-21-Mechanistic Target of Rapamycin Axis Via Suppression of Autophagy in Patients With Systemic Lupus Erythematosus
Hiroshi Kato et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study
Ronald F. van Vollenhoven et al.
LANCET (2018)
Precision DNA demethylation ameliorates disease in lupus-prone mice
Hao Li et al.
JCI INSIGHT (2018)
Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE
Cristina Rozo et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Update on Lupus Nephritis
Salem Almaani et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Lupus nephritis and B-cell targeting therapy
Matthias Cassia et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2017)
IL-23 Limits the Production of IL-2 and Promotes Autoimmunity in Lupus
Hong Dai et al.
JOURNAL OF IMMUNOLOGY (2017)
Metabolic Control of Immune System Activation in Rheumatic Diseases
Andras Perl
ARTHRITIS & RHEUMATOLOGY (2017)
Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3
Karel Pavelka et al.
ARTHRITIS RESEARCH & THERAPY (2017)
T cells and IL-17 in lupus nephritis
Tomohiro Koga et al.
CLINICAL IMMUNOLOGY (2017)
Efficacy of belimumab on renal outcomes in patients with systemic lupus erythematosus: A systematic review
S. Sciascia et al.
AUTOIMMUNITY REVIEWS (2017)
Tacrolimus use in lupus nephritis: A systematic review and meta-analysis
Jennifer Hannah et al.
AUTOIMMUNITY REVIEWS (2016)
Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients
Romain Banchereau et al.
CELL (2016)
Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration
Erik G. Gentry et al.
JOURNAL OF NEUROSCIENCE (2016)
Phosphatase PP2A is requisite for the function of regulatory T cells
Sokratis A. Apostolidis et al.
NATURE IMMUNOLOGY (2016)
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
Jing He et al.
NATURE MEDICINE (2016)
ICER is requisite for Th17 differentiation
Nobuya Yoshida et al.
NATURE COMMUNICATIONS (2016)
Lupus Nephritis IgG Induction of Calcium/Calmodulin-Dependent Protein Kinase IV Expression in Podocytes and Alteration of Their Function
Kunihiro Ichinose et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Calcium/Calmodulin-Dependent Kinase IV Facilitates the Recruitment of Interleukin-17-Producing Cells to Target Organs Through the CCR6/CCL20 Axis in Th17 Cell-Driven Inflammatory Diseases
Tomohiro Koga et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Risk of End-Stage Renal Disease in Patients With Lupus Nephritis, 1971-2015 A Systematic Review and Bayesian Meta-Analysis
Maria G. Tektonidou et al.
ARTHRITIS & RHEUMATOLOGY (2016)
IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment
Agneta Zickert et al.
BMC IMMUNOLOGY (2015)
Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity
Roba M. Talaat et al.
CYTOKINE (2015)
Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity
Patrick R. Burkett et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity
Vaishali R. Moulton et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
Christopher E. M. Griffiths et al.
LANCET (2015)
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
Iain B. McInnes et al.
LANCET (2015)
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
Dominique Baeten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
M. Lebwohl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis (vol 54, pg 39, 2015)
Takashi Kurita et al.
RHEUMATOLOGY (2015)
Ethnic specificity of lupus-associated loci identified in a genome-wide association study in Korean women
Hye-Soon Lee et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE
Tiffany N. Caza et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
KN-93, an inhibitor of calcium/calmodulin-dependent protein kinase IV, promotes generation and function of Foxp3+ regulatory T cells in MRL/lpr mice
Tomohiro Koga et al.
AUTOIMMUNITY (2014)
The role of T cells in systemic lupus erythematosus: an update
Christine Konya et al.
CURRENT OPINION IN RHEUMATOLOGY (2014)
cAMP Responsive Element Modulator (CREM) α Mediates Chromatin Remodeling of CD8 during the Generation of CD3+CD4-CD8- T Cells
Christian M. Hedrich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance
Tomohiro Koga et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
IL-2 Protects Lupus-Prone Mice from Multiple End-Organ Damage by Limiting CD4-CD8- IL-17-Producing T Cells
Masayuki Mizui et al.
JOURNAL OF IMMUNOLOGY (2014)
Mechanistic Target of Rapamycin Complex 1 Expands Th17 and IL-4+ CD4-CD8-Double-Negative T Cells and Contracts Regulatory T Cells in Systemic Lupus Erythematosus
Hiroshi Kato et al.
JOURNAL OF IMMUNOLOGY (2014)
Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis
Philip J. Mease et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Secukinumab in Plaque Psoriasis - Results of Two Phase 3 Trials
Richard G. Langley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Role of early repeated renal biopsies in lupus nephritis
A. Zickert et al.
LUPUS SCIENCE & MEDICINE (2014)
Enhanced Rho-Associated Protein Kinase Activation in Patients With Systemic Lupus Erythematosus
Josephine Isgro et al.
ARTHRITIS AND RHEUMATISM (2013)
Protein Phosphatase 2A Enables Expression of Interleukin 17 (IL-17) through Chromatin Remodeling
Sokratis A. Apostolidis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
cAMP-responsive Element Modulator α (CREMα) trans-Represses the Transmembrane Glycoprotein CD8 and Contributes to the Generation of CD3+CD4-CD8- T Cells in Health and Disease
Christian M. Hedrich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Mechanistic Target of Rapamycin Activation Triggers IL-4 Production and Necrotic Death of Double-Negative T Cells in Patients with Systemic Lupus Erythematosus
Zhi-Wei Lai et al.
JOURNAL OF IMMUNOLOGY (2013)
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
Iain B. McInnes et al.
LANCET (2013)
Clinical associations of serum interleukin-17 in systemic lupus erythematosus
Fabien B. Vincent et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Treatment with Anti-Interleukin 23 Antibody Ameliorates Disease in Lupus-Prone Mice
Vasileios C. Kyttaris et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Th17 cells in systemic lupus erythematosus share functional features with Th17 cells from normal bone marrow and peripheral tissues
Ana Henriques et al.
CLINICAL RHEUMATOLOGY (2012)
IL-17-producing γδ T cells and innate lymphoid cells
Caroline E. Sutton et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Cutting Edge: Protein Phosphatase 2A Confers Susceptibility to Autoimmune Disease through an IL-17-Dependent Mechanism
Jose C. Crispin et al.
JOURNAL OF IMMUNOLOGY (2012)
Calcium/Calmodulin-Dependent Protein Kinase IV Suppresses IL-2 Production and Regulatory T Cell Activity in Lupus
Tomohiro Koga et al.
JOURNAL OF IMMUNOLOGY (2012)
Gene expression of cytokines (TNF-α, IFN-γ), serum profiles of IL-17 and IL-23 in paediatric systemic lupus erythematosus
A. Rana et al.
LUPUS (2012)
Administration of fasudil, a ROCK inhibitor, attenuates disease in lupus-prone NZB/W F1 female mice
R. A. Stirzaker et al.
LUPUS (2012)
Protein tyrosine phosphatases in lymphocyte activation and autoimmunity
Inmoo Rhee et al.
NATURE IMMUNOLOGY (2012)
cAMP response element modulator α controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus
Christian M. Hedrich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
CREM overexpression decreases IL-2 production, induces a TH17 phenotype and accelerates autoimmunity
Ralph Lippe et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2012)
Follicular Helper CD4 T Cells (T-FH)
Shane Crotty
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Successful Treatment of Subacute Lupus Erythematosus With Ustekinumab
Aieska De Souza et al.
ARCHIVES OF DERMATOLOGY (2011)
Copy Number Variations of Interleukin-17F, Interleukin-21, and Interleukin-22 Are Associated With Systemic Lupus Erythematosus
Bo Yu et al.
ARTHRITIS AND RHEUMATISM (2011)
Targeting lymphocyte signaling pathways as a therapeutic approach to systemic lupus erythematosus
Vasileios C. Kyttaris et al.
CURRENT OPINION IN RHEUMATOLOGY (2011)
Transcriptional Activation of the cAMP-responsive Modulator Promoter in Human T Cells Is Regulated by Protein Phosphatase 2A-mediated Dephosphorylation of SP-1 and Reflects Disease Activity in Patients with Systemic Lupus Erythematosus
Yuang-Taung Juang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
cAMP-responsive Element Modulator (CREM)α Protein Induces Interleukin 17A Expression and Mediates Epigenetic Alterations at the Interleukin-17A Gene Locus in Patients with Systemic Lupus Erythematosus
Thomas Rauen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Cutting Edge: Calcium/Calmodulin-Dependent Protein Kinase Type IV Is Essential for Mesangial Cell Proliferation and Lupus Nephritis
Kunihiro Ichinose et al.
JOURNAL OF IMMUNOLOGY (2011)
IL-17-producing T cells in lupus nephritis
S. A. Apostolidis et al.
LUPUS (2011)
Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5
Xiang-Ping Yang et al.
NATURE IMMUNOLOGY (2011)
MECHANISMS OF DISEASE Systemic Lupus Erythematosus
George C. Tsokos
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Induction of PP2A Bβ, a regulator of IL-2 deprivation-induced T-cell apoptosis, is deficient in systemic lupus erythematosus
Jose C. Crispin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
IL-23: A Promising Therapeutic Target for Systemic Lupus Erythematosus
Rui-Xue Leng et al.
ARCHIVES OF MEDICAL RESEARCH (2010)
Expression of CD44 Variant Isoforms CD44v3 and CD44v6 Is Increased on T Cells From Patients With Systemic Lupus Erythematosus and Is Correlated With Disease Activity
Jose C. Crispin et al.
ARTHRITIS AND RHEUMATISM (2010)
The Mammalian Target of Rapamycin: Linking T Cell Differentiation, Function, and Metabolism
Jonathan D. Powell et al.
IMMUNITY (2010)
The IL-2 Defect in Systemic Lupus Erythematosus Disease Has an Expansive Effect on Host Immunity
Linda A. Lieberman et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice
Partha S. Biswas et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Cutting Edge: IL-23 Receptor Deficiency Prevents the Development of Lupus Nephritis in C57BL/6-lpr/lpr Mice
Vasileios C. Kyttaris et al.
JOURNAL OF IMMUNOLOGY (2010)
Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus
Jens Y. Humrich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
T Cell Activation
Jennifer E. Smith-Garvin et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Interleukin 2 and systemic lupus erythematosus Beyond the transcriptional regulatory net abnormalities
Diana Gomez-Martin et al.
AUTOIMMUNITY REVIEWS (2009)
The αβ T Cell Receptor Is an Anisotropic Mechanosensor
Sun Taek Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Methylation Status of CpG Islands Flanking a cAMP Response Element Motif on the Protein Phosphatase 2Acα Promoter Determines CREB Binding and Activity
Katsue Sunahori et al.
JOURNAL OF IMMUNOLOGY (2009)
Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus
Jian-Wen Han et al.
NATURE GENETICS (2009)
The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosus
Bonnie Ching-Ha Kwan et al.
RHEUMATOLOGY (2009)
Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells
Bing Yan et al.
ARTHRITIS AND RHEUMATISM (2008)
Ca2+/calmodulin-dependent protein kinases
M. T. Swulius et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: Implications for Th17-mediated inflammation in auto-immunity
Chun Kwok Wong et al.
CLINICAL IMMUNOLOGY (2008)
The biological functions of T helper 17 cell effector cytokines in inflammation
Wenjun Ouyang et al.
IMMUNITY (2008)
Structural Basis for CD44 Recognition by ERM Proteins
Tomoyuki Mori et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
PP2A dephosphorylates Elf-1 and determines the expression of CD3ζ and FcRγ in human systemic lupus erythematosus T cells
Yuang-Taung Juang et al.
JOURNAL OF IMMUNOLOGY (2008)
Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys
Jose C. Crispin et al.
JOURNAL OF IMMUNOLOGY (2008)
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
Craig L. Leonardi et al.
LANCET (2008)
Calcium/calmodulin-dependent kinase IV in immune and inflammatory responses: novel routes for an ancient traveller
Luigi Racioppi et al.
TRENDS IN IMMUNOLOGY (2008)
Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation
Arian Laurence et al.
IMMUNITY (2007)
Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus
Xavier Valencia et al.
JOURNAL OF IMMUNOLOGY (2007)
Phosphorylated ERM is responsible for increased T cell polarization, adhesion, and migration in patients with systemic lupus erythematosus
Yansong Li et al.
JOURNAL OF IMMUNOLOGY (2007)
Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus
S. Barath et al.
LUPUS (2007)
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene
Richard H. Duerr et al.
SCIENCE (2006)
Ca2+/calmodulin-dependent protein kinase II is a modulator of CARMA1-mediated NF-κB activation
Kazuhiro Ishiguro et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6
D Yen et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus
CG Katsiari et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages
LE Harrington et al.
NATURE IMMUNOLOGY (2005)
Active Ca2+/calmodulin-dependent protein kinase IIγB impairs positive selection of T cells by modulating TCR signaling
MA McGargill et al.
JOURNAL OF IMMUNOLOGY (2005)
Calmodulin-dependent protein kinase IV regulates nuclear export of Cabin1 during T-cell activation
F Pan et al.
EMBO JOURNAL (2005)
A pivotal role for the multifunctional calcium/calmodulin-dependent protein kinase II in T cells: From activation to unresponsiveness
MY Lin et al.
JOURNAL OF IMMUNOLOGY (2005)
Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV
YT Juang et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Cyclic adenosine 5'-monophosphate response element modulator is responsible for the decreased expression of c-fos and activator protein-1 binding in T cells from patients with systemic lupus erythematosus
VC Kyttaris et al.
JOURNAL OF IMMUNOLOGY (2004)
Roles of p-ERM and Rho-ROCK signaling in lymphocyte polarity and uropod formation
JH Lee et al.
JOURNAL OF CELL BIOLOGY (2004)
Divergent pro- and Antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation
CA Murphy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition
L Schiffer et al.
JOURNAL OF IMMUNOLOGY (2003)
The cyclic adenosine 5′-monophosphate response element modulator suppresses IL-2 production in stimulated T cells by a chromatin-dependent mechanism
K Tenbrock et al.
JOURNAL OF IMMUNOLOGY (2003)
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
DJ Cua et al.
NATURE (2003)
Requirement for Ca2+/calmodulin-dependent kinase type IV/Gr in setting the thymocyte selection threshold
V Raman et al.
JOURNAL OF IMMUNOLOGY (2001)
Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus
EE Solomou et al.
JOURNAL OF IMMUNOLOGY (2001)
Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus
CK Wong et al.
LUPUS (2000)
Share Paper
